Nisa Investment Advisors
KYTX icon

Nisa Investment Advisors’s Kyverna Therapeutics KYTX Stock Holding History

Nisa Investment Advisors’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.6K Hold
301
– – ﹤0.01% 2577
2025
Q4 		$2.83K Hold
301
– – ﹤0.01% 2553
2025
Q3 		$1.81K Hold
301
– – ﹤0.01% 2642
2025
Q2 		$924 Buy
301
+42
+16% +$104 ﹤0.01% 2752
2025
Q1 		$500 Sell
259
-105
-29% -$310 ﹤0.01% 2793
2024
Q4 		$1.36K Sell
364
-842
-70% -$4.03K ﹤0.01% 2601
2024
Q3 		$5.9K Buy
+1,206
New +$9.3K ﹤0.01% 2193

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Nisa Investment Advisors's KYTX Position: Q1 2026 in Review

Nisa Investment Advisors held its Kyverna Therapeutics (KYTX) position steady in Q1 2026 at 301 shares worth $2.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2577.

Nisa Investment Advisors first reported a position in KYTX in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.9K in Q3 2024. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • Nisa Investment Advisors held 301 shares of Kyverna Therapeutics worth $2.6K as of Q1 2026.
  • Nisa Investment Advisors left its Kyverna Therapeutics share count unchanged in Q1 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2577 holding.
  • Nisa Investment Advisors first reported a position in Kyverna Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Nisa Investment Advisors's Kyverna Therapeutics position peaked at $5.9K in Q3 2024.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.